Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response.

Jabalee J, Towle R, Lawson J, Dickman C, Garnis C.

Oncotarget. 2020 Feb 4;11(5):523-534. doi: 10.18632/oncotarget.27458. eCollection 2020 Feb 4.

2.

Prognostic biomarkers for malignant transformation of oral potentially malignant disorders: a scoping review protocol.

Mello FW, Melo G, da Silva Guerra EN, Warnakulasuriya S, Garnis C, Rivero ERC.

JBI Database System Rev Implement Rep. 2020 Jan 6. doi: 10.11124/JBISRIR-D-19-00259. [Epub ahead of print]

PMID:
31913186
3.

Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA Discovery.

Rock LD, Minatel BC, Marshall EA, Guisier F, Sage AP, Barros-Filho MC, Stewart GL, Garnis C, Lam WL.

Front Oncol. 2019 Nov 27;9:1305. doi: 10.3389/fonc.2019.01305. eCollection 2019.

4.

Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.

Pewarchuk ME, Barros-Filho MC, Minatel BC, Cohn DE, Guisier F, Sage AP, Marshall EA, Stewart GL, Rock LD, Garnis C, Lam WL.

Int J Mol Sci. 2019 Nov 14;20(22). pii: E5697. doi: 10.3390/ijms20225697.

5.

microRNAs in sudden hearing loss.

Nunez DA, Wijesinghe P, Nabi S, Yeh D, Garnis C.

Laryngoscope. 2019 Oct 11. doi: 10.1002/lary.28327. [Epub ahead of print]

PMID:
31603566
6.

Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy.

Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C, Daugaard M, Guns E, Hoorfar M, Li ITS.

APL Bioeng. 2019 Mar 27;3(1):011503. doi: 10.1063/1.5087122. eCollection 2019 Mar. Review.

7.

Previously undescribed thyroid-specific miRNA sequences in papillary thyroid carcinoma.

Barros-Filho MC, Pewarchuk M, Minatel BC, Sage AP, Marshall EA, Martinez VD, Rock LD, MacAulay G, Kowalski LP, Rogatto SR, Garnis C, Lam WL.

J Hum Genet. 2019 May;64(5):505-508. doi: 10.1038/s10038-019-0583-7. Epub 2019 Mar 6.

PMID:
30842597
8.

The association of Leptospermum honey with cytokine expression in the sinonasal epithelium of chronic rhinosinusitis patients.

Manji J, Thamboo A, Sunkaraneni V, Singh A, Tebbutt S, Garnis C, Javer A.

World J Otorhinolaryngol Head Neck Surg. 2018 Sep 7;5(1):19-25. doi: 10.1016/j.wjorl.2018.07.004. eCollection 2019 Mar.

9.

Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication.

Lawson J, Dickman C, Towle R, Jabalee J, Javer A, Garnis C.

Mol Carcinog. 2019 Mar;58(3):376-387. doi: 10.1002/mc.22935. Epub 2018 Nov 28.

PMID:
30362621
10.

The Role of Extracellular Vesicles in Cancer: Cargo, Function, and Therapeutic Implications.

Jabalee J, Towle R, Garnis C.

Cells. 2018 Aug 1;7(8). pii: E93. doi: 10.3390/cells7080093. Review.

11.

Identification of Malignancy-Associated Changes in Histologically Normal Tumor-Adjacent Epithelium of Patients with HPV-Positive Oropharyngeal Cancer.

Jabalee J, Carraro A, Ng T, Prisman E, Garnis C, Guillaud M.

Anal Cell Pathol (Amst). 2018 Mar 11;2018:1607814. doi: 10.1155/2018/1607814. eCollection 2018.

12.

The presence of Interleukin-13 in nasal lavage may be a predictor of nasal polyposis in pediatric patients with cystic fibrosis.

Manji J, Thamboo A, Tacey M, Garnis C, Chadha NK.

Rhinology. 2018 Sep 1;56(3):261-267. doi: 10.4193/Rhin17.007.

PMID:
29561922
13.

Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells.

Lawson J, Dickman C, MacLellan S, Towle R, Jabalee J, Lam S, Garnis C.

Oncotarget. 2017 Aug 7;8(48):83913-83924. doi: 10.18632/oncotarget.19996. eCollection 2017 Oct 13.

14.

Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes.

Dickman CT, Lawson J, Jabalee J, MacLellan SA, LePard NE, Bennewith KL, Garnis C.

Oncotarget. 2017 Feb 28;8(9):15252-15266. doi: 10.18632/oncotarget.14862.

15.

Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells.

Towle R, Truong D, Garnis C.

Genes Chromosomes Cancer. 2016 Jul;55(7):568-76. doi: 10.1002/gcc.22360. Epub 2016 May 2.

PMID:
27015871
16.

Lack of association between human herpesvirus and vestibular schwannoma: analysis of 121 cases.

Bhimrao SK, Maguire J, Garnis C, Tang P, Lea J, Akagami R, Westerberg BD.

Otolaryngol Head Neck Surg. 2015 Mar;152(3):513-7. doi: 10.1177/0194599814563517. Epub 2015 Jan 5.

PMID:
25560404
17.

Molecular characterization of immortalized normal and dysplastic oral cell lines.

Dickman CT, Towle R, Saini R, Garnis C.

J Oral Pathol Med. 2015 May;44(5):329-36. doi: 10.1111/jop.12236. Epub 2014 Aug 28.

PMID:
25169794
18.

Pre-profiling factors influencing serum microRNA levels.

MacLellan SA, MacAulay C, Lam S, Garnis C.

BMC Clin Pathol. 2014 Jun 21;14:27. doi: 10.1186/1472-6890-14-27. eCollection 2014.

19.

Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.

Towle R, Tsui IF, Zhu Y, MacLellan S, Poh CF, Garnis C.

Cancer Med. 2014 Oct;3(5):1170-84. doi: 10.1002/cam4.307. Epub 2014 Jul 24.

20.

Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.

Li G, van Niekerk D, Miller D, Ehlen T, Garnis C, Follen M, Guillaud M, Macaulay C.

Exp Mol Pathol. 2014 Apr;96(2):168-77. doi: 10.1016/j.yexmp.2013.12.007. Epub 2014 Jan 8.

21.

Global analysis of DNA methylation changes during progression of oral cancer.

Towle R, Truong D, Hogg K, Robinson WP, Poh CF, Garnis C.

Oral Oncol. 2013 Nov;49(11):1033-42. doi: 10.1016/j.oraloncology.2013.08.005. Epub 2013 Sep 13.

PMID:
24035722
22.

Differential expression of miRNAs in the serum of patients with high-risk oral lesions.

Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C.

Cancer Med. 2012 Oct;1(2):268-74. doi: 10.1002/cam4.17. Epub 2012 Jul 19.

23.

Methylation-mediated molecular dysregulation in clinical oral malignancy.

Towle R, Garnis C.

J Oncol. 2012;2012:170172. doi: 10.1155/2012/170172. Epub 2012 May 7.

24.

MicroRNAs in an oral cancer context - from basic biology to clinical utility.

Gorenchtein M, Poh CF, Saini R, Garnis C.

J Dent Res. 2012 May;91(5):440-6. doi: 10.1177/0022034511431261. Epub 2011 Dec 13. Review.

PMID:
22166582
25.

Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, Buys TP, Yee J, English JC, Macaulay C, Tsao MS, Gazdar AF, Minna JD, Lam S, Lam WL.

PLoS Med. 2010 Jul 27;7(7):e1000315. doi: 10.1371/journal.pmed.1000315.

26.

Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.

Chari R, Thu KL, Wilson IM, Lockwood WW, Lonergan KM, Coe BP, Malloff CA, Gazdar AF, Lam S, Garnis C, MacAulay CE, Alvarez CE, Lam WL.

Cancer Metastasis Rev. 2010 Mar;29(1):73-93. doi: 10.1007/s10555-010-9199-2. Review.

27.

Integrative molecular characterization of head and neck cancer cell model genomes.

Tsui IF, Garnis C.

Head Neck. 2010 Sep;32(9):1143-60. doi: 10.1002/hed.21311.

28.

A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.

Tsui IF, Garnis C, Poh CF.

Am J Surg Pathol. 2009 Nov;33(11):1732-8. doi: 10.1097/PAS.0b013e3181b669c2.

29.

Genomic imbalances in precancerous tissues signal oral cancer risk.

Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, Lam WL.

Mol Cancer. 2009 Jul 23;8:50. doi: 10.1186/1476-4598-8-50.

30.

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.

Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL.

Int J Cancer. 2009 Nov 1;125(9):2219-28. doi: 10.1002/ijc.24611.

31.

Diagnostic methods of lung cancer and its subtypes by comparative genomic hybridization.

Garnis C.

Expert Opin Med Diagn. 2007 Dec;1(4):541-4. doi: 10.1517/17530059.1.4.541.

PMID:
23496360
32.

High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.

Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL.

Int J Cancer. 2006 Mar 15;118(6):1556-64.

33.

Multiple microalterations detected at high frequency in oral cancer.

Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL.

Cancer Res. 2005 Sep 1;65(17):7561-7.

34.

High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples.

Garnis C, Coe BP, Lam SL, MacAulay C, Lam WL.

Genomics. 2005 Jun;85(6):790-3. Epub 2005 Apr 13.

PMID:
15885505
35.

Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.

Garnis C, Davies JJ, Buys TP, Tsao MS, MacAulay C, Lam S, Lam WL.

Oncogene. 2005 Jul 14;24(30):4806-12.

PMID:
15870700
36.

Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis.

Garnis C, Rosin MP, Zhang L, Lam WL.

Int J Cancer. 2005 Sep 20;116(5):813-9.

37.

Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis.

Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL.

Hum Mol Genet. 2005 Feb 15;14(4):475-82. Epub 2004 Dec 22.

PMID:
15615770
38.

High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines.

Coe BP, Henderson LJ, Garnis C, Tsao MS, Gazdar AF, Minna J, Lam S, Macaulay C, Lam WL.

Genes Chromosomes Cancer. 2005 Mar;42(3):308-13.

PMID:
15611929
39.

Genetic alteration on 8q distinct from MYC in bronchial carcinoma in situ lesions.

Garnis C, MacAulay C, Lam S, Lam W.

Lung Cancer. 2004 Jun;44(3):403-4. No abstract available.

PMID:
15140556
40.

Construction and optimization of chromosome arm-specific comparative genomic hybridization arrays for identifying genetic alterations in preinvasive lung cancers.

Garnis C, Coe B, Henderson LJ, Ishkanian A, Watson S, Marra M, Minna J, Lam S, MacAulay C, Lam W.

Chest. 2004 May;125(5 Suppl):104S-5S. No abstract available.

PMID:
15136441
41.

Genetic alteration and gene expression modulation during cancer progression.

Garnis C, Buys TP, Lam WL.

Mol Cancer. 2004 Mar 22;3:9. Review.

42.

OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis.

Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL.

Oral Oncol. 2004 May;40(5):511-9.

PMID:
15006624
43.
44.
45.

Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer.

Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL.

Genes Chromosomes Cancer. 2004 Jan;39(1):93-8.

PMID:
14603447
46.

An efficient method for the assessment of DNA quality of archival microdissected specimens.

Siwoski A, Ishkanian A, Garnis C, Zhang L, Rosin M, Lam WL.

Mod Pathol. 2002 Aug;15(8):889-92.

Supplemental Content

Loading ...
Support Center